CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2341-2353

  Borenstein, S H ^a   Graham, J ^a   Zhang, X L ^a   Chamberlain, J W ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; TRANSPLANTATION ANTIGEN;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; GENE EXPRESSION; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; XENOTRANSPLANTATION;

EID: 0034284431     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2341     Document Type: Article

References (76)

1. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
2. Ligand recognition by β T cell receptors
3. Antigen recognition by class I-restricted T lymphocytes
4. The cell biology of antigen processing and presentation
5. Tissue-specific and cell surface expression of human major histocompatibility complex class I heavy (HLA-B7) and light (β2-microglobulin) chain genes in transgenic mice
6. Major histocompatibility antigens: The human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules
7. Recognition of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system
8. Which T cells mediate allograft rejection?
9. The molecular basis of allorecognition
10. Transplantation and graft rejection
11. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens
12. Structure of the human class I histocompatibility antigen, HLA-A2
13. The role of 'indirect' recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice
14. Indirect presentation of MHC antigens in transplantation
15. Mechanisms oft cell recognition of antigen
16. MHC ligands and peptide motifs: First listing
17. Endothelial cell activation and thromboregulation during xenograft rejection
18. Delayed xenograft rejection
19. Organ transplantation between widely disparate species
20. Endothelial antigens recognized by xenoreactive human natural antibodies
21. Xenogeneic transplantation
22. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
23. Allogeneic and xenogeneic responses in mixed lymphocyte cultures
24. Murine major histocompatibility complex class-I mutants: Molecular analysis and structure-function implications
25. MHC class I transgenic mice
26. Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells
27. Cell surface expression and alloantigenic function of a human class I MHC heavy chain gene (HLA-B7) in transgenic mice
28. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice
29. Recognition of xeno-(HLA, SLA) MHC antigens by mouse cytotoxic T cells is not- H-2 restricted: A study with transgenic mice
30. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
31. Abrogation of H-2-restricted CTL responses and efficient recognition of HLA-A3 molecules in DBA/2 HLA-A24 responder mice
32. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice
33. Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B3501 transgenic mice
34. Cytotoxic T cell responses in HLA-A2.1 transgenic mice-recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element
35. 2m double transgenic mice
36. Strong xenogeneic HLA response in transgenic mice after introducing an α3 domain into HLA-B27
37. Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8
38. Human CD8 transgene regulation of HLA recognition by murine T cells
39. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells
40. b transgenic mice: Functional CTL repertoire and recognition of human A11-restricted CTL epitopes
41. 2m double knockout mice
42. HLA-restricted recognition of viral antigens in HLA transgenic mice
43. HLA-B27 in inbred and non-inbred transgenic mice
44. Self-tolerance to HLA focuses the response of immunized HLA transgenic mice on production of antibody to precise polymorphic HLA alloantigens
45. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2, HLA-B27.5, and HLA-Cw3 transgenic mice: A transgenic model for MHC xenoantigen recognition
46. Recognition of HLA-B27 by mouse cytotoxic T cell clones: A transgenic mouse model
47. 2-microglobulin: A model of human spondylarthropathies
48. CTL responses of HLA-A2.1 transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1
49. Species-specific differences in chaperone interaction of human and mouse MHC class I molecules
50. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator
51. A B cell-deficient mouse by the targeted disruption of the membrane exon of the immunoglobulin μ chain gene
52. CD8 is needed for development of cytotoxic T cells but not helper T cells
53. + cells but markedly decreased helper cell activity in mice lacking CD4
54. Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8
55. A 150-base pair 5' region of the MHC class I HLA-B7 gene is sufficient to direct tissue-specific expression and locus control region activity
56. Identification of cis sequences controlling efficient position-independent tissue-specific expression of human major histocompatibility complex class I genes in transgenic mice
57. Absence of polymorphism between HLA-B27 genomic exon sequences from normal donors and ankylosing spondylitis patients
58. Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse cells
59. Selection of highly transfectable variant from mouse mastocytoma P815
60. A human β-actin expression vector system directs high-level accumulation of antisense transcripts
61. Recognition of HLA-B27 and related antigen by a monoclonal antibody
62. A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and -B17
63. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal level of the cytolysis inhibiting effect of 7 monoclonal antibodies
64. Monoclonal antibodies to mouse MHC antigens
65. Chromium release assays for measuring CTL activity
66. Skin allograft rejection
67. Chromosomal mapping of the second human CD8B gene locus
68. Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K
69. b gene shows a cluster of seven nucleotide differences
70. Diversity and diversification of HLA-A, B, C alleles
71. Structural diversity of the classical H-2 genes: K, D and L
72. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences
73. Phenotype, specificity and function of T cell subsets and T cell interactions involved in skin allograft rejection
74. Cellular basis of skin allograft rejection
75. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat
76. Different requirements for the regulation of transplantation tolerance induction for allogeneic versus xenogeneic major histocompatibility complex antigens